{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Partial Response"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Complete Response"}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"}],"units":"Participants"}],"description":"Percentage of subjects with neither germline DNA repair mutations nor somatic BAP1 mutations who experienced partial or complete response.Response was assessed by the Response Evaluation Criteria in Solid Tumors (RECIST) v1.1, and the Malignant Pleural Mesothelioma (MPM) criteria. Partial Response is at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum of diameters. Complete Response is disappearance of all target lesions.","groups":[{"description":"Participants With no tumor tissue available for somatic mutation","id":"OG000","title":"Comparison Group 3: Participants With Neither Germline Mutations Nor BAP 1 Somatic Mutations"}],"paramType":"NUMBER","populationDescription":"Per protocol, this outcome measure was only assessed in participants in Comparison Group 3.","reportingStatus":"POSTED","timeFrame":"6 months after enrollment of last patient","title":"Percentage of Subjects With Neither Germline Deoxyribonuclecic Acid (DNA) Repair Mutations Nor Somatic Breast Cancer Type 1 Associated Protein-1 (BAP1) Mutations Who Experienced Partial or Complete Response.","type":"PRIMARY","unitOfMeasure":"percentage of participants"}